Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.41 USD | -10.75% | -11.93% | +9.29% |
Financials (USD)
Sales 2024 * | 28.26M | Sales 2025 * | 41.59M | Capitalization | 640M |
---|---|---|---|---|---|
Net income 2024 * | -163M | Net income 2025 * | -202M | EV / Sales 2024 * | 11.9 x |
Net cash position 2024 * | 304M | Net cash position 2025 * | 314M | EV / Sales 2025 * | 7.82 x |
P/E ratio 2024 * |
-3.93
x | P/E ratio 2025 * |
-3.82
x | Employees | 117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.1% |
Latest transcript on AnaptysBio, Inc.
1 day | -10.75% | ||
1 week | -11.93% | ||
Current month | -3.82% | ||
1 month | -5.34% | ||
3 months | +1.74% | ||
6 months | +63.71% | ||
Current year | +9.29% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 44 | 21-11-25 |
Dennis Mulroy
DFI | Director of Finance/CFO | 69 | 20-07-14 |
Paul Lizzul
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 77 | 15-06-29 |
Dennis Fenton
BRD | Director/Board Member | 72 | 18-03-04 |
Magda Marquet
BRD | Director/Board Member | 65 | 21-01-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 23.41 | -10.75% | 325,459 |
24-05-09 | 26.23 | +1.86% | 226,338 |
24-05-08 | 25.75 | +0.27% | 244,164 |
24-05-07 | 25.68 | -0.35% | 320,769 |
24-05-06 | 25.77 | -3.05% | 195,199 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.29% | 640M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ANAB Stock